Loading...
New Drugs on the Block—Emerging Treatments for Nonalcoholic Steatohepatitis
Patients with nonalcoholic steatohepatitis (NASH) are at higher risk of progression to advanced stages of fibrosis, cirrhosis, hepatocellular carcinoma and other end-stage liver disease complications. When addressing treatment of NASH, we have limited approved options, and the mainstay of therapy is...
Na minha lista:
| Udgivet i: | J Clin Transl Hepatol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
XIA & HE Publishing Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7868699/ https://ncbi.nlm.nih.gov/pubmed/33604255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2020.00057 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|